Strategic Alliance between Two Premier Community Blood Centers will Bring Synergies in Blood and Laboratory Services, Medical Programs, Cell Therapies and Research
PROVIDENCE, RI AND NEW YORK, NY (July 12, 2017) – New York Blood Center (NYBC) and Rhode Island Blood Center (RIBC) announced today that they are combining their operations to enhance one of the nation’s leading blood centers, serving patients and hospitals in the Northeast, Midwest and nationally.
The combination of the strengths of RIBC and NYBC provides the opportunity for greater breadth of services, efficiency and financial stability. The goal is to continue to provide the highest level of blood and hematology related products and services in a fast-changing environment for community blood centers nationwide. The new partnership with RIBC comes on the heels of NYBC’s highly successful 2014 alliance with Community Blood Center of Greater Kansas City (CBC) and more recently the merger with Innovative Blood Resources (IBR) in 2016.
The NYBC network of blood centers is responsible for providing over 800,000 units of blood annually, of which RIBC is currently responsible for approximately 75,000 units. RIBC will continue to be the primary supplier of blood and blood products to the hospitals in Rhode Island and throughout Southern New England.
“We’re extremely pleased to be partnering with such an excellent blood center,” said NYBC President and CEO Christopher D. Hillyer, MD. “NYBC and RIBC have a remarkable alignment of mission, vision and talent. We look forward to working together to ensure the finest customer-focused service for our hospitals and patients. We welcome RIBC to the NYBC family.”
“Our partnership with New York Blood Center, who we have worked with for decades, allows us to grow and expand our laboratory services with potential to add new customers,” said RIBC President and CEO Lawrence F. Smith. “We will initially add 15 new quality medical-technical jobs to our Providence location, while allowing us to expand into exciting new areas, such as translational and applied research that NYBC specializes in to help develop better treatments for all types of diseases."
RIBC’s customers, donors and volunteers will continue to receive the excellent service they’ve come to expect from the organization. Moreover, hospital customers will have access to an even broader range of blood products and services as a result of the partnership. The long-term goal of both organizations will be to maximize the operational synergies between the two organizations to the benefit of all members of the community.
About Rhode Island Blood Center
The Rhode Island Blood Center (RIBC) was founded in 1979 as a nonprofit community blood center. For over 35 years, RIBC has been the primary supplier of blood and blood products to patients being cared for in hospitals throughout Rhode Island and in neighboring states. Our mission is to help save lives by ensuring a safe, plentiful and cost-effective blood supply. RIBC is also part of the National Marrow Donor Program and collects stem cells for transplant right at its Providence location. RIBC provides therapeutic treatments for patients in local hospitals. Its state-of-the-art laboratory conducts human leukocyte antigen (HLA) histocompatibility and red cell typing, immunogenics, as well as DNA and relationship testing. RIBC is also involved in a variety of local and national research programs in an effort to improve all aspects of the blood supply.
About New York Blood Center
Founded in 1964, New York Blood Center (NYBC) is a nonprofit organization that is one of the largest independent, community-based blood centers in the world. NYBC, along with its partner organizations Community Blood Center of Kansas City, Missouri (CBC), and Innovative Blood Resources (IBR), based in St. Paul, Minnesota, collect approximately 3,500 units of blood products each day, serving local communities of more than 40 million people in New York, New Jersey, parts of Connecticut and Pennsylvania, the Kansas City metropolitan area, Minnesota, and Nebraska. NYBC and its partners also provide a wide array of transfusion-related medical services, including Comprehensive Cell Solutions, the National Center for Blood Group Genomics, the National Cord Blood Program, and the Lindsley F. Kimball Research Institute, which — among other milestones — developed the Hepatitis B vaccine and a patented solvent detergent plasma process innovating blood-purification technology worldwide.